Skip to main content
. 2021 Jan 1;11(1):304–315. doi: 10.7150/thno.45540

Figure 3.

Figure 3

177Lu-DOTA-Y003+Y003 treatment triggers tumor regression in mice. A. Treatment scheme of 177Lu-DOTA-Y003+Y003 in MC38 tumor-bearing mice. B. Individual tumor volume at the indicated time point after tumor implantation. C. Tumor growth curve of the indicated treatment groups. D. Summary of average survival time. E. Record of body weight of the indicated treatment groups. F. Summary of average survival time (n = 7-9/group).